Cong Xu
Private Equity Investor bij LAV Management Co., Ltd.
Profiel
Cong Xu is currently the Managing Director at LAV Management Co., Ltd.
He previously worked as the Vice President at IMPACT Therapeutics, Inc. from 2018 to 2019.
Mr. Xu graduated from Clemson University in 2012 with a graduate degree and obtained an MBA from the University of British Columbia in 2018.
Actieve functies van Cong Xu
Bedrijven | Functie | Begin |
---|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | 01-01-2018 |
Eerdere bekende functies van Cong Xu
Bedrijven | Functie | Einde |
---|---|---|
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | President | 01-12-2019 |
Opleiding van Cong Xu
Clemson University | Graduate Degree |
University of British Columbia | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Health Technology |